机译:固态NMR在HIV-1 Gp120结合到447-52D抗体Fv片段的V3环上产生结构约束
Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-0520;
Department of Structural Biology, The Weizmann Institute of Science, Rehovot, Israel 76100;
Department of Structural Biology, The Weizmann Institute of Science, Rehovot, Israel 76100;
Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-0520;
Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-0520;
机译:固态NMR证据表明HIV-1 gp120的V3环具有抗体依赖性构象
机译:通过固态NMR REDOR测量探测与抗体结合的HIV-1 gp120 V3环中的氢键
机译:靶向HIV-1 GP120 V3环的生物活性单链可变抗体片段的制备
机译:HIV-1 GP120 V3 - CCR5共受体N末端相互作用的NMR结构分析
机译:蛋白质相互作用和基于知识的药物设计的研究:(A)HIV-1 gp120 V3环与共受体CCR5 / CXCR4之间识别的静电性质,(B)坎普他汀家族肽对补体系统的抑制作用
机译:靶向HIV-1 GP120 V3环的生物活性单链可变抗体片段的制备
机译:增加的表位复杂性与抗体亲和力成熟相关的表位复杂性和通过兔抗体的结构揭示的新型结合模式对HIV-1GP120的第三可变环(V3)的结构